Formyl peptide receptors: A promiscuous subfamily of G protein-coupled receptors controlling immune responses

Cytokine and Growth Factor Reviews

Volumn 17, Issue 6, 2006, Pages 501-519

  Migeotte, Isabelle ^a   Communi, David ^a   Parmentier, Marc ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Formyl peptide receptors; G protein coupled receptors; Leukocyte chemoattractants; Multigene families

Indexed keywords

CATHEPSIN G; CHEMOKINE; FORMYLPEPTIDE RECEPTOR; FPR1 RECEPTOR; G PROTEIN COUPLED RECEPTOR; HUMANIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; LIPOCORTIN 1; LIPOXIN A; PEPTIDE ANTIBODY; PEPTIDE DERIVATIVE; PEPTIDE LIBRARY; PROTEIN; UNCLASSIFIED DRUG; UROKINASE; UROKINASE RECEPTOR; VIRUS ENVELOPE PROTEIN;

ALZHEIMER DISEASE; CHEMOTAXIS; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; IMMUNOREGULATION; MOLECULAR CLONING; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION;

AMINO ACID SEQUENCE; ANIMALS; CLONING, MOLECULAR; HUMANS; LIGANDS; MICE; MOLECULAR SEQUENCE DATA; PHYLOGENY; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

BACTERIA (MICROORGANISMS); PRIMATES;

EID: 33751211223     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2006.09.009     Document Type: Review

References (150)

1. Le Y.Y., Murphy P.M., and Wang J.M. Formyl-peptide receptors revisited. Trends Immunol 23 (2002) 541-548
2. Boulay F., Tardif M., Brouchon L., and Vignais P. Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA. Biochem Biophys Res Commun 168 (1990) 1103-1109
3. Perez H.D., Holmes R., Kelly E., Mcclary J., Chou Q., and Andrews W.H. Cloning of the gene coding for a human receptor for formyl peptides-characterization of a promoter region and evidence for polymorphic expression. Biochemistry 31 (1992) 11595-11599
4. Ye R.D., Cavanagh S.L., Quehenberger O., Prossnitz E.R., and Cochrane C.G. isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor. Biochem Biophys Res Commun 184 (1992) 582-589
5. Bao L., Gerard N.P., Eddy R.L., Shows T.B., and Gerard C. Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19. Genomics 13 (1992) 437-440
6. Murphy P.M., Ozcelik T., Kenney R.T., Tiffany H.L., Mcdermott D., and Francke U. A structural homolog of the N-formyl peptide receptor-characterization and chromosome mapping of a peptide chemoattractant receptor family. J Biol Chem 267 (1992) 7637-7643
7. Alvarez V., Coto E., Setien F., and Lopezlarrea C. A Physical map of two clusters containing the genes for 6 proinflammatory receptors. Immunogenetics 40 (1994) 100-103
8. Durstin M., Gao J.L., Tiffany H.L., Mcdermott D., and Murphy P.M. Differential expression of members of the N-formylpeptide receptor gene-cluster in human phagocytes. Biochem Biophys Res Commun 201 (1994) 174-179
9. Gwinn M.R., Sharma A., and De Nardin E. Single nucleotide polymorphisms of the N-formyl peptide receptor in localized juvenile periodontitis. J Periodontol 70 (1999) 1194-1201
10. Sahagun-Ruiz A., Colla J.S., Juhn J., Gao J.L., Murphy P.M., and McDermott D.H. Contrasting evolution of the human leukocyte N-formylpeptide receptor subtypes FPR and FPRL1R. Genes Immun 2 (2001) 335-342
11. Alvarez V., Coto E., Setien F., GonzalezRoces S., and Lopezlarrea C. Molecular evolution of the N-formyl peptide and C5a receptors in non-human primates. Immunogenetics 44 (1996) 446-452
12. Gao J.L., and Murphy P.M. Species and subtype variants of the N-formyl peptide chemotactic receptor reveal multiple important functional domains. J Biol Chem 268 (1993) 25395-25401
13. Takano T., Fiore S., Maddox J.F., Brady H.R., Petasis N.A., and Serhan C.N. Aspirin-triggered 15-Epi-Lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J Exp Med 185 (1997) 1693-1704
14. Gao J.L., Chen H., Filie J.D., Kozak C.A., and Murphy P.M. Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse. Genomics 51 (1998) 270-276
15. Hartt J.K., Barish G., Murphy P.M., and Gao J.L. N-formylpeptides induce two distinct concentration optima for mouse neutrophil chemotaxis by differential interaction with two N-formylpeptide receptor (FPR) subtypes: molecular characterization of FPR2, a second mouse neutrophil FPR. J Exp Med 190 (1999) 741-747
16. Wang Z.G., and Ye R.D. Characterization of two new members of the formyl peptide receptor gene family from 129S6 mice. Gene 299 (2002) 57-63
17. Ye R.D., Quehenberger O., Thomas K.M., Navarro J., Cavanagh S.L., Prossnitz E.R., et al. The rabbit neutrophil N-formyl peptide receptor-cDNA cloning, expression, and structure-function implications. J Immunol 150 (1993) 1383-1394
18. Chiang N., Takano T., Arita M., Watanabe S., and Serhan C.N. A novel rat lipoxin A(4) receptor that is conserved in structure and function. Br J Pharmacol 139 (2003) 89-98
19. Becker E.L., Forouhar F.A., Grunnet M.L., Boulay F., Tardif M., Bormann B.J., et al. Broad immunocytochemical localization of the formylpeptide receptor in human organs, tissues, and cells. Cell Tissue Res 292 (1998) 129-135
20. Le Y., Oppenheim J.J., and Wang J.M. Pleiotropic roles of formyl peptide receptors. Cytokine Growth Factor Rev 12 (2001) 91-105
21. Czapiga M., Gao J.L., Kirk A., and Lekstrom-Himes J. Human platelets exhibit chemotaxis using functional N-formyl peptide receptors. Exp Hematol 33 (2005) 73-84
22. VanCompernolle S.E., Clark K.L., Rummel K.A., and Todd S.C. Expression and function of formyl peptide receptors on human fibroblast cells. J Immunol 171 (2003) 2050-2056
23. Harada M., Habata Y., Hosoya M., Nishi K., Fujii R., Kobayashi M., et al. N-formylated humanin activates both formyl peptide receptor-Like 1 and 2. Biochem Biophys Res Commun 324 (2004) 255-261
24. Yang D., Chen Q., Gertz B., He R., Phulsuksombati M., Ye R.D., et al. Human dendritic cells express functional formyl peptide receptor-Like-2 (FPRL2) throughout maturation. J Leukoc Biol 72 (2002) 598-607
25. Yang D., Chen Q., Le Y.Y., Wang J.M., and Oppenheim J.J. Differential regulation of formyl peptide receptor-Like 1 expression during the differentiation of monocytes to dendritic cells and macrophages. J Immunol 166 (2001) 4092-4098
26. Migeotte I., Riboldi E., Franssen J.D., Gregoire F., Loison U., Wittamer V., et al. Identification and characterization of an endogenous chemotactic ligand specific for FPRL2. J Exp Med 201 (2005) 83-93
27. Lee H.Y., Kang H.K., Jo E.J., Kim J.I., Lee Y.N., Lee S.H., et al. Trp-Lys-Tyr-Met-Val-Met stimulates phagocytosis via phospholipase D-dependent signaling in mouse dendritic cells. Exp Mol Med 36 (2004) 135-144
28. Mandal P., Novotny M., and Hamilton T.A. Lipopolysaccharide induces formyl peptide receptor 1 gene expression in macrophages and neutrophils via transcriptional and posttranscriptional mechanisms. J Immunol 175 (2005) 6085-6091
29. Dai Y., Major J., Novotny M., and Hamilton T.A. IL-4 inhibits expression of the formyl peptide receptor gene in mouse peritoneal macrophages. J Interferon Cytokine Res 25 (2005) 11-19
30. Iribarren P., Cui Y.H., Le Y., Ying G.G., Zhang X., Gong W.H., et al. IL-4 down-regulates lipopolysaccharide-induced formyl peptide receptor 2 in murine microglial cells by inhibiting the activation of mitogen-activated protein kinases. J Immunol 171 (2003) 5482-5488
31. Iribarren P., Chen K., Hu J., Gong W., Cho E.H., Lockett S., et al. CpG-containing oligodeoxynucleotide promotes microglial cell uptake of amyloid & beta; 1-42 peptide by up-regulating the expression of the G protein-coupled receptor mFPR2. FASEB J (2005) 05-4578fje
32. Iribarren P., Chen K., Hu J., Zhang X., Gong W., and Wang J.M. IL-4 inhibits the expression of mouse formyl peptide receptor 2, a receptor for amyloid {beta} 1-42, in TNF-{alpha}-activated microglia. J Immunol 175 (2005) 6100-6106
33. Selvatici R., Falzarano S., Mollica A., and Spisani S. Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils. Eur J Pharmacol 534 (2006) 1-11
34. Fu H., Karlsson J., Bylund J., Movitz C., Karlsson A., and Dahlgren C. Ligand recognition and activation of formyl peptide receptors in neutrophils. J Leukoc Biol 79 (2006) 247-256
35. Christophe T., Karlsson A., Dugave C., Rabiet M.J., Boulay F., and Dahlgren C. The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A(4) receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2. J Biol Chem 276 (2001) 21585-21593
36. Wenzel-Seifert K., Arthur J.M., Liu H.Y., and Seifert R. Quantitative analysis of formyl peptide receptor coupling to G(i)alpha(1) G(i)alpha(2), and G(i)alpha(3). J Biol Chem 274 (1999) 33259-33266
37. Amatruda T.T., Dragasgraonic S., Holmes R., and Perez H.D. Signal-transduction by the formyl peptide receptor-studies using chimeric receptors and site-directed mutagenesis define a novel domain for interaction with G proteins. J Biol Chem 270 (1995) 28010-28013
38. Del Prete A., Vermi W., Dander E., Otero K., Barberis L., Luini W., et al. Defective dendritic cell migration and activation of adaptive immunity in PI3K gamma-deficient mice. Embo J 23 (2004) 3505-3515
39. Bae Y.S., Song J.Y., Kim Y., He R., Ye R.D., Kwak J.Y., et al. Differential activation of formyl peptide receptor signaling by peptide ligands. Mol Pharmacol 64 (2003) 841-847
40. Paruch S., El Benna J., Djerdjouri B., Marullo S., and eacuterianin A. A role of p44/42 mitogen-activated protein kinases in formyl-peptide receptor-mediated phospholipase D activity and oxidant production. FASEB J (2005) 05-3881fje
41. Wenzel-Seifert K., Hurt C.M., and Seifert R. High constitutive activity of the human formyl peptide receptor. J Biol Chem 273 (1998) 24181-24189
42. Partida-Sanchez S., Iribarren P., Moreno-Garcia M.E., Gao X.L., Murphy P.M., Oppenheimer N., et al. Chemotaxis and calcium responses of phagocytes to formyl peptide receptor ligands is differentially regulated by cyclic ADP ribose. J Immunol 172 (2004) 1896-1906
43. Partida-Sanchez S., Cockayne D.A., Monard S., Jacobson E.L., Oppenheimer N., Garvy B., et al. Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo. Nat Med 7 (2001) 1209-1216
44. Boulay F., and Rabiet M.J. The chemoattractant receptors FPR and C5aR: same functions-different fates. Traffic 6 (2005) 83-86
45. Suvorova E.S., Gripentrog J.M., and Miettinen H.M. Different endocytosis pathways of the C5a receptor and the N-formyl peptide receptor. Traffic 6 (2005) 100-115
46. Ernst S., Zobiack N., Boecker K., Gerke V., and Rescher U. Agonist-induced trafficking of the low-affinity formyl peptide receptor FPRL1. Cell Mol Life Sci 61 (2004) 1684-1692
47. Rabiet M.J., Huet E., and Boulay F. Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR. Eur J Immunol 35 (2005) 2486-2495
48. Gao J.L., Becker E.L., Freer R.J., Muthukumaraswamy N., and Murphy P.M. A high potency nonformylated peptide agonist for the phagocyte N-formylpeptide chemotactic receptor. J Exp Med 180 (1994) 2191-2197
49. Higgins J.D., Bridger G.J., Derian C.K., Beblavy M.J., Hernandez P.E., Gaul F.E., et al. N-terminus urea-substituted chemotactic peptides: new potent agtagonists and antagonists toward the neutrophil fMLF receptor. J Med Chem 39 (1996) 1013-1015
50. Derian C.K., Solomon H.F., Higgins J.D., Beblavy M.J., Santulli R.J., Bridger G.J., et al. Selective inhibition of N-formylpeptide-induced neutrophil activation by carbamate-modified peptide analogues. Biochemistry 35 (1996) 1265-1269
51. Carp H. Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J Exp Med 155 (1982) 264-275
52. Baek S.H., Seo J.K., Chae C.B., Suh P.G., and Ryu S.H. Identification of the peptides that stimulate the phosphoinositide hydrolysis in lymphocyte cell lines from peptide libraries. J Biol Chem 271 (1996) 8170-8175
53. Seo J.K., Choi S.Y., Kim Y., Baek S.H., Kim K.T., Chae C.B., et al. A peptide with unique receptor specificity: stimulation of phosphoinositide hydrolysis and induction of superoxide generation in human neutrophils. J Immunol 158 (1997) 1895-1901
54. Bae Y.S., Kim Y., Kim Y., Kim J.H., Suh P.G., and Ryu S.H. Trp-Lys-Tyr-Met-Val-D-Met is a chemoattractant for human phagocytic cells. J Leukoc Biol 66 (1999) 915-922
55. Le Y.Y., Gong W.H., Li B.Q., Dunlop N.M., Shen W.P., Su S.B., et al. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-Like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. J Immunol 163 (1999) 6777-6784
56. Karlsson J., Fu H.M., Boulay F., Bylund J., and Dahlgren C. The peptide Trp-Lys-Tyr-Met-Val-D-Met activates neutrophils through the formyl peptide receptor only when signaling through the formylpeptde receptor Like 1 is blocked-a receptor switch with implications for signal transduction studies with inhibitors and receptor antagonists. Biochem Pharmacol 71 (2006) 1488-1496
57. Kang H.K., Lee H.Y., Kim M.K., Park K.S., Park Y.M., Kwak J.Y., et al. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met inhibits human monocyte-derived dendritic cell maturation via formyl peptide receptor and formyl peptide receptor-Like 2. J Immunol 175 (2005) 685-692
58. Su S.B., Gong W.H., Gao J.L., Shen W.P., Grimm M.C., Deng X.Y., et al. T20/DP178, an ectodomain peptide of human immunodeficiency virus type 1 gp41, is an activator of human phagocyte N-formyl peptide receptor. Blood 93 (1999) 3885-3892
59. Braun M.C., Wang J.M., Lahey E., Rabin R.L., and Kelsall B.L. Activation of the formyl peptide receptor by the HIV-derived peptide T-20 suppresses interleukin-12 p70 production by human monocytes. Blood 97 (2001) 3531-3536
60. Bellner L., Thoren F., Nygren E., Liljeqvist J.A., Karlsson A., and Eriksson K. A proinflammatory peptide from herpes simplex virus type 2 glycoprotein g affects neutrophil, monocyte, and nk cell functions. J Immunol 174 (2005) 2235-2241
61. Walther A., Riehemann K., and Gerke V. A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. Mol Cell 5 (2000) 831-840
62. Rosengarth A., and Luecke H. A Calcium-driven Conformational switch of the N-terminal and Core domains of annexin A1. J Mol Biol 326 (2003) 1317-1325
63. Solito E., Kamal A., Russo-Marie F., Buckingham J.C., Marullo S., and Perretti M. A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophils. Faseb J 17 (2003)
64. Arur S., Uche U.E., Rezaul K., Fong M., Scranton V., Cowan A.E., et al. Annexin I Is an endogenous ligand that mediates apoptotic cell engulfment. Dev Cell 4 (2003) 587-598
65. Hayhoe R.P.G., Kamal A.M., Solito E., Flower R.J., Cooper D., and Perretti M. Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. Blood 107 (2006) 2123-2130
66. Perretti M. The annexin 1 receptor(s): is the plot unravelling?. Trends in Pharmacol Sci 24 (2003) 574-579
67. Perretti M., Ingegnoli F., Wheller S.K., Blades M.C., Solito E., and Pitzalis C. Annexin 1 modulates monocyte-endothelial cell interaction in vitro and cell migration in vivo in the human SCID mouse transplantation model. J Immunol 169 (2002) 2085-2092
68. Perretti M., Getting S.J., Solito E., Murphy P.M., and Gao J.L. Involvement of the Receptor for formylated peptides in the in vivo anti-migratory actions of annexin 1 and its mimetics. Am J Pathol 158 (2001) 1969-1973
69. Gavins F.N.E., Yona S., Kamal A.M., Flower R.J., and Perretti M. Leukocyte antiadhesive actions of annexin 1: ALYR- and FPR-related anti-inflammatory mechanisms. Blood 101 (2003) 4140-4147
70. Gavins F.N.E., Kamal A.M., D'Amico M., Oliani S.M., and Perretti M. Formyl-peptide receptor is not involved in the protection afforded by annexin 1 in murine acute myocardial infarct. FASEB J (2004) 04-2178fje
71. Karlsson J., Fu H., Boulay F., Dahlgren C., Hellstrand K., and Movitz C. Neutrophil NADPH-oxidase activation by an annexin AI peptide is transduced by the formyl peptide receptor (FPR), whereas an inhibitory signal is generated independently of the FPR family receptors. J Leukoc Biol 78 (2005) 762-771
72. Sun R.H., Iribarren P., Zhang N., Zhou Y., Gong W.H., Cho E.H., et al. Identification of neutrophil granule protein cathepsin G as a novel chemotactic agonist for the G protein-coupled formyl peptide receptor. J Immunol 173 (2004) 428-436
73. Yamamoto Y., Kanazawa T., Shimamura M., Ueki M., and Hazato T. Inhibitory effects of spinorphin, a novel endogenous regulator, on chemotaxis, O-2 generation, and exocytosis by N-formylmethionyl-leucyl-phenylalanine (FMLP)-stimulated neutrophils. Biochem Pharmacol 54 (1997) 695-701
74. Liang T.S., Gao J.L., Fatemi O., Lavigne M., Leto T.L., and Murphy P.M. The endogenous opioid spinorphin blocks fMet-leu-phe-induced neutrophil chemotaxis by acting as a specific antagonist at the N-formylpeptide receptor subtype FPR. J Immunol 167 (2001) 6609-6614
75. Haas P.J., de Haas C.J.C., Kleibeuker W., Poppelier M.J.J.G., van Kessel K.P.M., Kruijtzer J.A.W., et al. N-terminal residues of the chemotaxis inhibitory protein of staphylococcus aureus are essential for blocking formylated peptide receptor but not C5a receptor. J Immunol 173 (2004) 5704-5711
76. Lee H.Y., Kang H.K., Yoon H.R., Kwak J.Y., and Bae Y.S. Lysophosphatidic acid is a mediator of Trp-Lys-Tyr-Met-Val-D-Met-induced calcium influx. Biochem Biophys Res Commun 324 (2004) 458-465
77. Jo E.J., Lee H.Y., Kim J.I., Kang H.K., Lee Y.N., Kwak J.Y., et al. Activation of formyl peptide receptor-Like 1 by WKYMVm induces serine phosphorylation of STAT3, which inhibits its tyrosine phosphorylation and nuclear translocation induced by hydrogen peroxide. Life Sci 75 (2004) 2217-2232
78. Bae Y.S., Park E.Y., Kim Y., He R., Ye R.D., Kwak J.Y., et al. Novel chemoattractant peptides for human leukocytes. Biochem Pharmacol 66 (2003) 1841-1851
79. Bae Y.S., Yi H.J., Lee H.Y., Jo E.J., Kim J.I., Lee T.G., et al. Differential activation of formyl peptide receptor-Like 1 by peptide ligands. J Immunol 171 (2003) 6807-6813
80. Bae Y.S., Bae H., Kim Y., Lee T.G., Suh P.G., and Ryu S.H. Identification of novel chemoattractant peptides for human leukocytes. Blood 97 (2001) 2854-2862
81. Bae Y.S., Lee H.Y., Jo E.J., Kim J.I., Kang H.K., Ye R.D., et al. Identification of peptides that antagonize formyl peptide receptor-Like 1-mediated signaling. J Immunol 173 (2004) 607-614
82. Klein C., Paul J.I., Sauve K., Schmidt M.M., Arcangeli L., Ransom J., et al. Identification of surrogate agonists for the human FPRL-1 receptor by autocrine selection in yeast. Nat Biotechnol 16 (1998) 1334-1337
83. Hu J.Y., Le Y.Y., Gong W.H., Dunlop N.M., Gao J.L., Murphy P.M., et al. Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1. J Leukoc Biol 70 (2001) 155-161
84. Nanamori M., Cheng X.Y., Mei J.H., Sang H.R., Xuan Y.X., Zhou C.H., et al. A novel nonpeptide ligand for formyl peptide receptor-Like 1. Mol Pharmacol 66 (2004) 1213-1222
85. Su S.B., Gao J.L., Gong W.H., Dunlop N.M., Murphy P.M., Oppenheim J.J., et al. T21/DP107, a synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G protein-coupled formyl peptide receptors. J Immunol 162 (1999) 5924-5930
86. Shen W.P., Li B.Q., Wetzel M.A., Rogers T.J., Henderson E.E., Su S.B., et al. Down-regulation of the chemokine receptor CCR5 by activation of chemotactic formyl peptide receptor in human monocytes. Blood 96 (2000) 2787-2794
87. Deng X., Ueda H., Su S.B., Gong W., Dunlop N.M., Gao J.L., et al. A Synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G protein-coupled receptor FPRL1/LXA4R. Blood 94 (1999) 1165-1173
88. Le Y.Y., Jiang S., Hu J.Y., Gong W.H., Su S.B., Dunlop N.M., et al. N36, a synthetic N-terminal heptad repeat domain of the HIV-1 envelope protein gp41, is an activator of human phagocytes. Clin Immunol 96 (2000) 236-242
89. Betten A., Bylund J., Cristophe T., Boulay F., Romero A., Hellstrand K., et al. A proinflammatory peptide from Helicobacter pylori activates monocytes to induce lymphocyte dysfunction and apoptosis. J Clin Invest 108 (2001) 1221-1228
90. Bylund J., Karlsson A., Boulay F., and Dahlgren C. Lipopolysaccharide-induced granule mobilization and priming of the neutrophil response to Helicobacter pylori peptide Hp(2-20), which activates formyl peptide receptor-Like 1. Infect Immun 70 (2002) 2908-2914
91. de Paulis A., Prevete N., Fiorentino I., Walls A.F., Curto M., Petraroli A., et al. Basophils infiltrate human gastric mucosa at sites of Helicobacter pylori infection, and exhibit chemotaxis in response to H-pylori-derived peptide hp(2-20)(1). J Immunol 172 (2004) 7734-7743
92. Chiang N., Fierro I.M., Gronert K., and Serhan C.N. Activation of lipoxin A4 receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J Exp Med 191 (2000) 1197-1208
93. Shawar S.M., Rich R.R., and Becker E.L. Peptides from the amino-terminus of mouse mitochondrially encoded nadh dehydrogenase subunit 1 are potent chemoattractants. Biochem Biophys Res Commun 211 (1995) 812-818
94. Wang C.R., Castano A.R., Peterson P.A., Slaughter C., Lindahl K.F., and Deisenhofer J. Nonclassical binding of formylated peptide in crystal-structure of the Mhc Class-Ib molecule H2-M3. Cell 82 (1995) 655-664
95. Fiore S., Maddox J.F., Perez H.D., and Serhan C.N. Identification of a human cDNA-encoding a functional high-affinity lipoxin A(4) receptor. J Exp Med 180 (1994) 253-260
96. Chiang N., Bermudez E.A., Ridker P.M., Hurwitz S., and Serhan C.N. Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial. PNAS 101 (2004) 15178-15183
97. Simoes R.L., and Fierro I.M. Involvement of the Rho-Kinase/Myosin light chain kinase pathway on human monocyte chemotaxis induced by ATL-1, an aspirin-triggered lipoxin A4 synthetic analog. J Immunol 175 (2005) 1843-1850
98. Ariel A., Chiang N., Arita M., Petasis N.A., and Serhan C.N. Aspirin-Triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-{alpha} secretion from human T Cells. J Immunol 170 (2003) 6266-6272
99. Fierro I.M., Colgan S.P., Bernasconi G., Petasis N.A., Clish C.B., Arita M., et al. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells. J Immunol 170 (2003) 2688-2694
100. Maddox J.F., Hachicha M., Takano T., Petasis N.A., Fokin V.V., and Serhan C.N. Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G protein-linked lipoxin A4 receptor. J Biol Chem 272 (1997) 6972-6978
101. Maddox J.F., and Serhan C.N. Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction. J Exp Med 183 (1996) 137-146
102. Aliberti J., Hieny S., Sousa C.R.E., Serhan C.N., and Sher A. Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat Immunol 3 (2002) 76-82
103. Devchand P.R., Arita M., Hong S., Bannerberg G., Moussignac R.L., Gronert K., et al. Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense. FASEB J 17 (2003) 652-659
104. Levy B.D., DeSanctis G.T., Devchand P.R., Kim E., Ackerman K., Schmidt B.A., et al. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nat Med 8 (2002) 1018-1023
105. Brink C., Dahlen S.E., Drazen J., Evans J.F., Hay D.W.P., Nicosia S., et al. International Union of pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors. Pharmacol Rev 55 (2003) 195-227
106. Perretti M., Chiang N., La M., Fierro I.M., Marullo S., Getting S.J., et al. Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A(4) receptor. Nat Med 8 (2002) 1296-1302
107. Yang D., Chen Q., Schmidt A.P., Anderson G.M., Wang J.M., Wooters J., et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-Like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 192 (2000) 1069-1074
108. Tjabringa G.S., Ninaber D.K., Drijfhout J.W., Rabe K.F., and Hiemstra P.S. Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors. Int Arch Allergy Immunol 140 (2006) 103-112
109. Koczulla R., von Degenfeld G., Kupatt C., Krotz F., Zahler S., Gloe T., et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 111 (2003) 1665-1672
110. Nagaoka I., Tamura H., and Hirata M. An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the Activation of formyl-peptide receptor-Like 1 and P2X7. J Immunol 176 (2006) 3044-3052
111. Chen Q., Wade D., Kurosaka K., Wang Z.Y., Oppenheim B.J., and Yang D. Temporin a and related frog antimicrobial peptides use formyl peptide receptor-Like 1 as a receptor to chemoattract phagocytes. J Immunol 173 (2004) 2652-2659
112. Elagoz A., Henderson D., Babu P.S., Salter S., Grahames C., Bowers L., et al. A truncated form of CK beta 8-1 is a potent agonist for human formyl peptide-receptor-Like 1 receptor. Br J Pharmacol 141 (2004) 37-46
113. Resnati M., Pallavicini I., Wang J.M., Oppenheim J., Serhan C.N., Romano M., et al. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. PNAS 99 (2002) 1359-1364
114. de Paulis A., Montuori N., Prevete N., Fiorentino I., Rossi F.W., Visconte V., et al. Urokinase induces basophil chemotaxis through a urokinase receptor or epitope that is an endogenous ligand for formyl peptide receptor-Like 1 and -Like 2. J Immunol 173 (2004) 5739-5748
115. Forman M.S., Trojanowski J.Q., and Lee V.M.Y. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 10 (2004) 1055-1063
116. Le Y.Y., Yazawa H., Gong W.H., Yu Z.X., Ferrans V.J., Murphy P.M., et al. Cutting edge: the neurotoxic prion peptide fragment PrP106-126 is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-Like 1. J Immunol 166 (2001) 1448-1451
117. Su S.B., Gong W.H., Gao J.L., Shen W.P., Murphy P.M., Oppenheim J.J., et al. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J Exp Med 189 (1999) 395-402
118. Lee H.Y., Kim M.K., Park K.S., Bae Y.H., Yun J., Park J.I., et al. Serum amyloid A stimulates matrix-metalloproteinase-9 upregulation via formyl peptide receptor Like-1-mediated signaling in human monocytic cells. Biochem Biophys Res Commun 330 (2005) 989-998
119. He R., Sang H.R., and Ye R.D. Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. Blood 101 (2003) 1572-1581
120. Lee H.Y., Kim M.K., Park K.S., Shin E.H., Jo S.H., Kim S.D., et al. Serum amyloid A induces contrary immune responses via formyl peptide receptor Like-1 in human monocytes. Mol Pharmacol 70 (2006) 241-248
121. Le Y., Gong W., Tiffany H.L., Tumanov A., Nedospasov S., Shen W., et al. Amyloid {beta}42 activates a G protein-coupled chemoattractant receptor, FPR-Like-1. J Neurosci 21 (2001) RC123:1-RC123:5
122. Yazawa H., Yu Z.X., TAKEDA, Le Y., Giolitti A., Ferrans V.J., et al. {beta} amyloid peptide (A{beta}42) is internalized via the G protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages. FASEB J 15 (2001) 2454-2462
123. Tajima H., Niikura T., Hashimoto Y., Ito Y., Kita Y., Terashita K., et al. Evidence for in vivo production of Humanin peptide, a neuroprotective factor against Alzheimer's disease-related insults. Neurosci Lett 324 (2002) 227-231
124. Hashimoto Y., Niikura T., Ito Y., Sudo H., Hata M., Arakawa E., et al. Detailed characterization of neuroprotection by a rescue factor humanin against various Alzheimer's disease-relevant insults. J Neurosci 21 (2001) 9235-9245
125. Guo B., Zhai D., Cabezas E., Welsh K., Nouraini S., Satterthwait A.C., et al. Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature 423 (2003) 456-461
126. Ikonen M., Liu B., Hashimoto Y., Ma L., Lee K.W., Niikura T., et al. Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis. PNAS 100 (2003) 13042-13047
127. Ying G., Iribarren P., Zhou Y., Gong W., Zhang N., Yu Z.X., et al. Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-Like-1 as a functional receptor. J Immunol 172 (2004) 7078-7085
128. Hashimoto Y., Suzuki H., Aiso S., Niikura T., Nishimoto I., and Matsuoka M. Involvement of tyrosine kinases and STAT3 in humanin-mediated neuroprotection. Life Sci 77 (2005) 3092-3104
129. Kim Y., Lee B.D., Kim O., Bae Y.S., Lee T., Suh P.G., et al. Pituitary adenylate cyclase-activating polypeptide 27 is a functional ligand for formyl peptide receptor-Like 1. J Immunol 176 (2006) 2969-2975
130. Ernst S., Lange C., Wilbers A., Goebeler V., Gerke V., and Rescher U. An annexin 1 N-terminal peptide activates leukocytes by triggering different members of the formyl peptide receptor family. J Immunol 172 (2004) 7669-7676
131. Shin E.H., Lee H.Y., Kim S.D., Jo S.H., Kiin M.K., Park K.S., et al. Trp-Arg-Trp-Trp-Trp-Trp antagonizes formyl peptide receptor Like 2-mediated signaling. Biochem Biophys Res Commun 341 (2006) 1317-1322
132. Gao J.L., Lee E.J., and Murphy P.M. Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor. J Exp Med 189 (1999) 657-662
133. Lavigne M.C., Murphy P.M., Leto T.L., and Gao J.L. The N-formylpeptide receptor (FPR) and a second G(i)-coupled receptor mediate fMet-Leu-Phe-stimulated activation of NADPH oxidase in murine neutrophils. Cell Immunol 218 (2002) 7-12
134. Vaughn M.W., Proske R.J., and Haviland D.L. Identification, cloning, and functional characterization of a murine lipoxin A4 receptor homologue gene. J Immunol 169 (2002) 3363-3369
135. Tiffany H.L., Lavigne M.C., Cui Y.H., Wang J.M., Leto T.L., Gao J.L., et al. Amyloid-beta induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain. J Biol Chem 276 (2001) 23645-23652
136. Cui Y.H., Le Y.Y., Yazawa H., Gong W.H., and Wang J.M. Potential role of the formyl peptide receptor-Like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease. J Leukoc Biol 72 (2002) 628-635
137. Liang T.S., Wang J.M., Murphy P.M., and Gao J.L. Serum amyloid A is a chemotactic agonist at FPR2, a low-affinity N-formylpeptide receptor on mouse neutrophils. Biochem Biophys Res Commun 270 (2000) 331-335
138. Kurosaka K., Chen Q., Yarovinsky F., Oppenheim J.J., and Yang D. Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-Like 1/Mouse formyl peptide receptor-Like 2 as the Receptor and acts as an immune adjuvant. J Immunol 174 (2005) 6257-6265
139. Perez H.D., Holmes R., Vilander L.R., Adams R.R., Manzana W., Jolley D., et al. Formyl Peptide Receptor Chimeras Define Domains Involved in Ligand-Binding. J Biol Chem 268 (1993) 2292-2295
140. Gao J.L., and Murphy P.M. Analysis of the ligand-binding site of the human N-formyl peptide receptor. Biophys J 64 (1993) A83-A83
141. Quehenberger O., Pan Z.K., Prossnitz E.R., Cavanagh S.L., Cochrane C.G., and Ye R.D. Identification of an N-foumyl peptide receptor ligand binding domain by a gain-of-function approach. Biochem Biophys Res Commun 238 (1997) 377-381
142. Perez H.D., Vilander L., Andrews W.H., and Holmes R. Human formyl peptide receptor-ligand binding domain(S)-Studies using an improved mutagenesis/expression vector reveal a novel mechanism for the regulation of receptor occupancy. J Biol Chem 269 (1994) 22485-22487
143. Lala A., Gwinn M., and De Nardin E. Human formyl peptide receptor function - Role of conserved and nonconserved charged residues. Eur J Biochem 264 (1999) 495-499
144. Quehenberger O., Prossnitz E.R., Cavanagh S.L., Cochrane C.G., and Ye R.D. Multiple domains of the N-formyl peptide receptor are required for high-affinity ligand-binding-construction and analysis of chimeric N-formyl peptide receptors. J Biol Chem 268 (1993) 18167-18175
145. Le Y., Ye R.D., Gong W., Li J., Iribarren P., and Wang J.M. Identification of functional domains in the formyl peptide receptor-Like 1 for agonist-induced cell chemotaxis. FEBS J 272 (2005) 769-778
146. Zhou Y., Bian X., Le Y., Gong W., Hu J., Zhang X., et al. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. J Natl Cancer Inst 97 (2005) 823-835
147. Hu J., Li G., Tong Y., Li Y., Zhou G., He X., et al. Transduction of the gene coding for a human G protein coupled receptor FPRL1 in mouse tumor cells increases host anti-tumor immunity. Int Immunopharmacol 5 (2005) 971-980
148. Perretti M., and Flower R.J. Annexin 1 and the biology of the neutrophil. J Leukoc Biol 76 (2004) 25-29
149. Shen W., Proost P., Li B., Gong W., Le Y., Sargeant R., et al. Activation of the chemotactic peptide receptor FPRL1 in monocytes phosphorylates the chemokine receptor CCR5 and attenuates cell responses to selected chemokines. Biochem Biophys Res Commun 272 (2000) 276-283
150. Wenzel-Seifert K., Kobilka B.K., and Seifert R. The formyl peptide receptor coupled to the G protein G(i alpha 2)beta(1)gamma(2) is constitutively active: suppression of spontaneous activity by the inverse agonist cyclosporin H. Naunyn-Schmiedebergs Arch Pharmacol 358 (1998) R657-R657